Oruka Therapeutics, Inc. logo

Oruka Therapeutics, Inc. (ORKA)

Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
92. 11
-0.51
-0.5506%
After Hours
$
94. 00
+1.89 +2.0519%
5.59B Market Cap
- P/E Ratio
6.45% Div Yield
590,651 Volume
- Eps
$ 92.62
Previous Close
Add Transaction
Day Range
90.4 92.87
Year Range
14.67 115.52
Want to track ORKA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Oruka Therapeutics, Inc. logo
ORKA Oruka Therapeutics, Inc.
12 May 2026
-
-
Oruka Therapeutics, Inc. logo
ORKA Oruka Therapeutics, Inc.
5 Mar 2026
-
-
Oruka Therapeutics, Inc. logo
ORKA Oruka Therapeutics, Inc.
11 Nov 2025
-
-
Oruka Therapeutics, Inc. logo
ORKA Oruka Therapeutics, Inc.
7 Aug 2025
-
-
Oruka Therapeutics, Inc. logo
ORKA Oruka Therapeutics, Inc.
23 Apr 2025
-
-
Oruka Therapeutics, Inc. logo
ORKA Oruka Therapeutics, Inc.
7 Mar 2025
-
-
Oruka Therapeutics, Inc. logo
ORKA Oruka Therapeutics, Inc.
16 Oct 2024
-
-

ORKA Earnings Reports FAQ

What is the earnings per share (EPS) for ORKA?

EPS data for ORKA is currently not available, as Oruka Therapeutics, Inc has not reported recent earnings.

What is the company's earnings growth rate?

Oruka Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Oruka Therapeutics, Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Oruka Therapeutics, Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ORKA at this time, as Oruka Therapeutics, Inc has no recent EPS data to calculate it.